JPMorgan is cutting off OxyContin maker Purdue Pharma - JPMorgan's decision underscores a drive among banks to reassess their relationships with clients and industries in response to controversy and political debates over matters such as immigration detention and mass shootings. [More]So can Purdue Pharma, in turn, require as a condition of sale that no prescriptions for their products may be written for any employee or stockholder of JPMorgan?
[Via Bluesgal]
No comments:
Post a Comment